Indivior PLC
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly … Read more
Indivior PLC (INDV) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.612x
Based on the latest financial reports, Indivior PLC (INDV) has a cash flow conversion efficiency ratio of -0.612x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX158.00 Million) by net assets (GBX-258.00 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Indivior PLC - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Indivior PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Indivior PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Indivior PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LUMBER LIQ HLDG
BE:LKU
|
-0.183x |
|
Gabelli Global Utility & Income Tr
NYSE MKT:GLU
|
N/A |
|
Strive Total Return Bond ETF
NYSE:STXT
|
N/A |
|
EDENRED (QSV.SG)
STU:QSV
|
0.077x |
|
Maj Invest Glob Akt non fossil
CO:MAJGANF
|
N/A |
|
Entergy Arkansas LLC Deb 2066
NYSE:EAI
|
0.014x |
|
BROWN NON VTG-B - Dusseldorf Stock Exchang
DU:BF5B
|
0.005x |
|
TDSPU
OTCGREY:TDSPU
|
N/A |
Annual Cash Flow Conversion Efficiency for Indivior PLC (2011–2024)
The table below shows the annual cash flow conversion efficiency of Indivior PLC from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX-348.00 Million | GBX36.00 Million | -0.103x | -100.36% |
| 2023-12-31 | GBX-11.00 Million | GBX-315.00 Million | 28.636x | +36611.36% |
| 2022-12-31 | GBX51.00 Million | GBX-4.00 Million | -0.078x | -104.51% |
| 2021-12-31 | GBX203.00 Million | GBX353.00 Million | 1.739x | +173.88% |
| 2020-12-31 | GBX82.00 Million | GBX-193.00 Million | -2.354x | -425.77% |
| 2019-12-31 | GBX209.00 Million | GBX151.00 Million | 0.722x | -84.26% |
| 2018-12-31 | GBX66.00 Million | GBX303.00 Million | 4.591x | +415.92% |
| 2017-12-31 | GBX-203.00 Million | GBX295.00 Million | -1.453x | -5.33% |
| 2016-12-31 | GBX-295.00 Million | GBX407.00 Million | -1.380x | -20.29% |
| 2015-12-31 | GBX-279.00 Million | GBX320.00 Million | -1.147x | -23.82% |
| 2014-12-31 | GBX-475.00 Million | GBX440.00 Million | -0.926x | +92.27% |
| 2013-12-31 | GBX-66.00 Million | GBX791.00 Million | -11.985x | -300.67% |
| 2012-12-31 | GBX145.00 Million | GBX866.00 Million | 5.972x | +112.17% |
| 2011-12-31 | GBX254.00 Million | GBX715.00 Million | 2.815x | -- |